M A Nooy

2.0k total citations
28 papers, 1.4k citations indexed

About

M A Nooy is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Oncology. According to data from OpenAlex, M A Nooy has authored 28 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 9 papers in Rheumatology and 7 papers in Oncology. Recurrent topics in M A Nooy's work include Sarcoma Diagnosis and Treatment (13 papers), Bone Tumor Diagnosis and Treatments (9 papers) and Ovarian cancer diagnosis and treatment (6 papers). M A Nooy is often cited by papers focused on Sarcoma Diagnosis and Treatment (13 papers), Bone Tumor Diagnosis and Treatments (9 papers) and Ovarian cancer diagnosis and treatment (6 papers). M A Nooy collaborates with scholars based in Netherlands, Italy and France. M A Nooy's co-authors include J. L. Bloem, Pancras C.W. Hogendoorn, J. Hermans, A. H. M. Taminiau, Herma C. Holscher, Frits R. Rosendaal, H. J. van der Woude, A. H. M. Taminiau, Nir I. Weijl and Susanne Osanto and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Radiology.

In The Last Decade

M A Nooy

28 papers receiving 1.4k citations

Peers

M A Nooy
Harald Hoekstra Netherlands
Stephanie A. Howard United States
Solomon L. Woldu United States
Maike de Wit Germany
Dayron Rodríguez United States
Auke Beishuizen Netherlands
Harald Hoekstra Netherlands
M A Nooy
Citations per year, relative to M A Nooy M A Nooy (= 1×) peers Harald Hoekstra

Countries citing papers authored by M A Nooy

Since Specialization
Citations

This map shows the geographic impact of M A Nooy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M A Nooy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M A Nooy more than expected).

Fields of papers citing papers by M A Nooy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M A Nooy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M A Nooy. The network helps show where M A Nooy may publish in the future.

Co-authorship network of co-authors of M A Nooy

This figure shows the co-authorship network connecting the top 25 collaborators of M A Nooy. A scholar is included among the top collaborators of M A Nooy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M A Nooy. M A Nooy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Keizer, R. J. W. de, D. de Wolff–Rouendaal, & M A Nooy. (2008). Angiosarcoma of the Eyelid and Periorbital Region. Experience in Leiden with Iridium192Brachytherapy and Low-Dose Doxorubicin Chemotherapy. Orbit. 27(1). 5–12. 12 indexed citations
2.
Tesselaar, Margot, Jannemieke Ouwerkerk, M A Nooy, Frits R. Rosendaal, & S. Osanto. (2004). Risk factors for catheter-related thrombosis in cancer patients. European Journal of Cancer. 40(15). 2253–2259. 96 indexed citations
3.
Molenaar, Sjaak, Paul Oosterveld, Piet Bakker, et al.. (2001). The decisional conflict scale: further validation in two samples of Dutch oncology patients. Patient Education and Counseling. 45(3). 187–193. 108 indexed citations
4.
Bloem, Johan L., et al.. (1998). Chondroblastic osteosarcoma: characterisation by gadolinium-enhanced MR imaging correlated with histopathology. Skeletal Radiology. 27(3). 145–153. 20 indexed citations
5.
Jansen, S.J.T., Anne M. Stiggelbout, Peter P. Wakker, et al.. (1998). Patients' Utilities for Cancer Treatments. Medical Decision Making. 18(4). 391–399. 79 indexed citations
6.
7.
Pujade-Lauraine, Éric, Jean‐Paul Guastalla, Nicoletta Colombo, et al.. (1996). Intraperitoneal recombinant interferon gamma in ovarian cancer patients with residual disease at second-look laparotomy.. Journal of Clinical Oncology. 14(2). 343–350. 130 indexed citations
8.
Woude, H. J. van der, J. L. Bloem, J A van Oostayen, et al.. (1995). Treatment of high-grade bone sarcomas with neoadjuvant chemotherapy: the utility of sequential color Doppler sonography in predicting histopathologic response.. American Journal of Roentgenology. 165(1). 125–133. 31 indexed citations
9.
Canevari, Silvana, Gerrit Stoter, Flavio Arienti, et al.. (1995). Regression of Advanced Ovarian Carcinoma by Intraperitoneal Treatment With Autologous TLymphocytes Retargeted by a Bispecific Monoclonal Antibody. JNCI Journal of the National Cancer Institute. 87(19). 1463–1469. 147 indexed citations
10.
Holscher, Herma C., J. L. Bloem, J. Hermans, et al.. (1995). Can MRI predict the histopathological response in patients with osteosarcoma after the first cycle of chemotherapy?. Clinical Radiology. 50(6). 384–390. 45 indexed citations
11.
Woude, H. J. van der, J. L. Bloem, Koenraad Verstraete, et al.. (1995). Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery.. American Journal of Roentgenology. 165(3). 593–598. 120 indexed citations
12.
Holscher, Herma C., H. J. van der Woude, J. Hermans, et al.. (1994). Magnetic resonance relaxation times of normal tissue in the course of chemotherapy: a study in patients with bone sarcoma. Skeletal Radiology. 23(3). 181–185. 6 indexed citations
13.
Veenhof, C.H.N., M.E.L. van der Burg, M A Nooy, et al.. (1994). Phase II study of high-dose megestrol acetate in patients with advanced ovarian carcinoma. European Journal of Cancer. 30(5). 697–698. 24 indexed citations
14.
Woude, H. J. van der, J. L. Bloem, Herma C. Holscher, et al.. (1994). Monitoring the effect of chemotherapy in Ewing's sarcoma of bone with MR imaging. Skeletal Radiology. 23(7). 493–500. 34 indexed citations
15.
Souhami, R L, Jeremy Whelan, M A Nooy, et al.. (1994). Doxorubicin and cisplatin with granulocyte colony-stimulating factor as adjuvant chemotherapy for osteosarcoma: phase II trial of the European Osteosarcoma Intergroup.. Journal of Clinical Oncology. 12(9). 1842–1848. 23 indexed citations
16.
Pujade-Lauraine, Éric, Nicoletta Colombo, Éric François, et al.. (1993). [Intraperitoneal administration of interferon gamma. An efficient adjuvant to the chemotherapy of ovarian cancers. Apropos of an European study of 108 patients].. PubMed. 80(2). 163–70. 4 indexed citations
17.
Beex, L.V.A.M., et al.. (1992). Dose intensity of chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil in the elderly with advanced breast cancer. European Journal of Cancer. 28(2-3). 686–690. 9 indexed citations
18.
Holscher, Herma C., J. L. Bloem, D. Vanel, et al.. (1992). Osteosarcoma: chemotherapy-induced changes at MR imaging.. Radiology. 182(3). 839–844. 82 indexed citations
19.
Holscher, Herma C., J. L. Bloem, M A Nooy, et al.. (1990). The value of MR imaging in monitoring the effect of chemotherapy on bone sarcomas.. American Journal of Roentgenology. 154(4). 763–769. 68 indexed citations
20.
Heintz, A. Peter M., et al.. (1988). The treatment of advanced ovarian carcinoma (I): Clinical variables associated with prognosis. Gynecologic Oncology. 30(3). 347–358. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026